Incidence of Parkinsonism As a Complication of Anti-BCMA CAR-T Cell Therapy in Multiple Myeloma

被引：2
|
作者：
Singh, Vaishnavi [1 ]
Master, Samip [1 ]
机构：
[1] Willis Knighton Hlth Syst, Shreveport, LA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-188090
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Monitoring of Anti-BCMA CAR-T Cells and non-CAR-T Immune Subsets in Multiple Myeloma Patients
    Venglar, Ondrej
    Viera, Hrabcakova
    Soucek, Ondrej
    Kutejova, Kamila
    Mihalyova, Jana
    Muronova, Ludmila
    Popkova, Tereza
    Zihala, David
    Sevcikova, Tereza
    Broskevicova, Lucie
    Hajek, Roman
    Folber, Frantisek
    Radocha, Jakub
    Jelinek, Tomas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S95 - S95
  • [22] A combination of humanized anti-BCMA and murine anti-CD38 CAR-T cell therapy in patients with relapsed or refractory multiple myeloma
    Zhang, Huan
    Liu, Man
    Xiao, Xia
    Lv, Hairong
    Jiang, Yanyu
    Li, Xin
    Yuan, Ting
    Zhao, Mingfeng
    LEUKEMIA & LYMPHOMA, 2022, 63 (06) : 1418 - 1427
  • [23] GUILLAIN-BARRE SYNDROME FOLLOWING ANTI-BCMA CAR-T CELL THERAPY
    Rutenberg, David
    CHEST, 2023, 164 (04) : 6183A - 6184A
  • [24] Safety and efficacy of anti-BCMA CAR-T cell therapy in older adults with multiple myeloma: A systematic review and meta-analysis
    Akhtar, Othman Salim
    Sheeba, Ba Aqeel
    Azad, Farhan
    Alessi, Lauren
    Hansen, Doris
    Alsina, Melissa
    Baz, Rachid
    Shain, Kenneth
    Cruz, Ariel Grajales
    Puglianini, Omar Castaneda
    Liu, Hien
    Blue, Brandon
    Nishihori, Taiga
    Al Jumayli, Mohammed
    Extermann, Martine
    Locke, Frederick L.
    Mhaskar, Rahul
    Freeman, Ciara Louise
    JOURNAL OF GERIATRIC ONCOLOGY, 2024, 15 (02)
  • [25] High Efficacy and Safety of Nanobody Based Anti-BCMA CAR-T Cell Therapy in Treating Patients with Relapsed or Refractory Multiple Myeloma
    Zhang, Xian
    Wang, Lin
    Yang, Junfang
    Li, Jingjing
    Liu, Hongxing
    Li, Jianqiang
    Lu, Peihua
    BLOOD, 2023, 142
  • [26] Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myeloma
    Jinhuan Xu
    Qiuxiang Wang
    Hao Xu
    Chaojiang Gu
    Lijun Jiang
    Jue Wang
    Di Wang
    Bin Xu
    Xia Mao
    Jin Wang
    Zhiqiong Wang
    Yi Xiao
    Yicheng Zhang
    Chunrui Li
    Jianfeng Zhou
    Journal of Hematology & Oncology, 11
  • [27] Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myeloma
    Xu, Jinhuan
    Wang, Qiuxiang
    Xu, Hao
    Gu, Chaojiang
    Jiang, Lijun
    Wang, Jue
    Wang, Di
    Xu, Bin
    Mao, Xia
    Wang, Jin
    Wang, Zhiqiong
    Xiao, Yi
    Zhang, Yicheng
    Li, Chunrui
    Zhou, Jianfeng
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [28] Cardiovascular adverse events and outcomes after anti-BCMA CAR-T for relapsed and refractory multiple myeloma
    Stefanie Palfi
    Lauren C. Peres
    Himara Koelmeyer
    Melissa Alsina
    Rachid C. Baz
    Brandon J. Blue
    Salvatore Corallo
    Gabriel De Avila
    Ciara Freeman
    Rebecca Gonzalez
    Ariel Grajales-Cruz
    Kristy Harvey
    Hien D. Liu
    Taiga Nishihori
    Guilherme H. Oliveira
    Laura B. Oswald
    Omar Castaneda Puglianini
    Sruthi Selvakumar
    Alexis Behne Sharma
    Elicia Wang
    Kenneth H. Shain
    Michael Jain
    Frederick L. Locke
    Mohammed Alomar
    Doris K. Hansen
    Dae Hyun Lee
    Blood Cancer Journal, 15 (1)
  • [29] Monitoring anti-BCMA CAR T-Cell Therapy with bb2121 in relapsed multiple myeloma
    Seipel, K.
    Wiedemann, G.
    Jeker, B.
    Porret, N.
    Taleghani, B. Mansouri
    Bacher, U.
    Pabst, T.
    SWISS MEDICAL WEEKLY, 2021, 151 : 24 - 24
  • [30] P-BCMA-ALLO1-a nonviral, allogeneic anti-BCMA CAR-T therapy with potent antitumor function for the treatment of multiple myeloma
    Richter, Maximilian
    Cranert, Stacey
    Tan, Yening
    Tong, Min
    Domingo, Christine
    Argus, Elvira
    Ibitokou, Samad
    Smith, Jenessa
    Martin, Christopher
    Wang, Xinxin
    Barnett, Burton
    Ostertag, Eric
    Coronella, Julia
    Shedlock, Devon
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
12345